greater/protease

FIELD OF THE INVENTION The present invention relates to compositions that comprise modified variant Bowman Birk Protease Inhibitor proteins (BBPIs). The modified variant BBPIs comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity

1. FIELD OF THE INVENTION The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the

SEQUENCE LISTING The sequence listing submitted via EFS, in compliance with 37 C.F.R. .sctn.1.52(e), is incorporated herein by reference. The sequence listing text file submitted via EFS contains the file "31151D1C1_CorrectedSequenceListing.txt" created on Jun. 23, 2011, which is 227,126 bytes in

1. FIELD OF THE INVENTION The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the

1. FIELD OF THE INVENTION The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the use of an Aspergillus oryzae protease preparation as an anti-inflammatory agent useful in the treatment of various diseases and conditions. 2. Background of the Invention Proteolytic enzymes have been used

BACKGROUND OF THE INVENTION Therapeutic proteins provide enormous potential for the treatment of human disease. Dozens of protein therapeutics are currently available, with hundreds more in clinical development (PhRMA 2004). Such proteins include human growth hormone, which is used to treat abnormal

This invention relates to a Bacillus licheniformis derived protease preparation having substantially reduced allergenic properties and being useful as a commercial protease product, for example for admixture into detergent compositions, such as washing powder compositions for domestic

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to unique oral dosage formulations of 5,6-dihydro-4-hydroxy-2-pyrones compounds. In particular, the present invention relates to a substantially alcohol-free and propylene glycol-free, microemulsion formulation of

BACKGROUND OF THE INVENTION The present invention relates to enzyme recovery and purification and, more particularly, to a process for the recovery of a purified alkaline protease from Bacillus licheniformis and Bacillus alcalophilus, or genetically engineered variants of these, and the composition

BACKGROUND OF THE INVENTION The present invention relates to enzyme recovery and purification and, more particularly, to a process for the recovery of a purified alkaline protease from Bacillus licheniformis and Bacillus alcalophilus, or genetically engineered variants of these, and the composition

BACKGROUND OF THE INVENTION Enzymes have been used for numerous industrial, commercial and research purposes. In the laundry detergent field, however, they have only recently been included in various synthetic detergent mixtures, whether in dry, solid phase, or in liquid phase. Approximately twenty

FIELD OF THE INVENTION This invention relates to substrates for herpesvirus proteases, to methods of determining the activity of herpesvirus proteases and to methods of identifying inhibitors of herpesvirus proteases. BACKGROUND OF THE INVENTION Herpesviruses inflict a wide range of diseases against

BACKGROUND OF THE INVENTION The ability of an enzyme to discriminate among many potential substrates is an important factor in maintaining the fidelity of most biological functions. While substrate selection can be regulated on many levels in a biological context, such as spatial and temporal

FIELD OF THE INVENTION The present invention relates to a novel proteolytic enzyme. In particular, the present invention relates to a novel proteolytic enzyme with broad specificity and alkali and thermal stability. The present invention also relates to a process for preparing the enzyme. BACKGROUND